Finally, viral genotype is an important consideration for the treatment of EBV+ PTLD, as we observe different requirements for PI3K p110α activation by B95.8 and tumor variant LMP1 in the regulation of miR-155 and FOXO3a. This evidence concerns the gene PDLIM7 and neoplasm.